In the inorganic arsenic (iAs)-induced T2DM, iAs treatment promoted translocation of METL14 and IGF2BP2 to the nucleus and activated m6A-mediated (METTL14-mediated) NOD-like receptor protein 3 (NLRP3) inflammasome. The gene discussed is METTL14; the disease is type 2 diabetes mellitus.